These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33921715)

  • 1. Current Strategies in Assessment of Nanotoxicity: Alternatives to In Vivo Animal Testing.
    Huang HJ; Lee YH; Hsu YH; Liao CT; Lin YF; Chiu HW
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for the optimisation of in vivo experiments in accordance with the 3Rs philosophy.
    Madden JC; Hewitt M; Przybylak K; Vandebriel RJ; Piersma AH; Cronin MT
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):140-54. PubMed ID: 22446816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refinement, Reduction, and Replacement of Animal Toxicity Tests by Computational Methods.
    Ford KA
    ILAR J; 2016 Dec; 57(2):226-233. PubMed ID: 28053075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternatives to animal testing: A review.
    Doke SK; Dhawale SC
    Saudi Pharm J; 2015 Jul; 23(3):223-9. PubMed ID: 26106269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward Nano-Specific In Silico NAMs: How to Adjust Nano-QSAR to the Recent Advancements of Nanotoxicology?
    Ciura K; Moschini E; Stępnik M; Serchi T; Gutleb A; Jarzyńska K; Jagiello K; Puzyn T
    Small; 2024 Feb; 20(6):e2305581. PubMed ID: 37775952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement, reduction and refinement.
    Flecknell P
    ALTEX; 2002; 19(2):73-8. PubMed ID: 12098013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico cancer research towards 3R.
    Jean-Quartier C; Jeanquartier F; Jurisica I; Holzinger A
    BMC Cancer; 2018 Apr; 18(1):408. PubMed ID: 29649981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Indicator Approach for Assessment of Nanotoxicity of Two-Dimensional Nanomaterials.
    Tsukanov AA; Turk B; Vasiljeva O; Psakhie SG
    Nanomaterials (Basel); 2022 Feb; 12(4):. PubMed ID: 35214977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal experimentation: implementation and application of the 3Rs.
    Lewis DI
    Emerg Top Life Sci; 2019 Nov; 3(6):675-679. PubMed ID: 32915219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animals and the 3Rs in toxicology research and testing: The way forward.
    Stokes WS
    Hum Exp Toxicol; 2015 Dec; 34(12):1297-303. PubMed ID: 26614819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation and enforcement of the 3Rs principle in the field of transgenic animals used for scientific purposes. Report and recommendations of the BfR expert workshop, May 18-20, 2009, Berlin, Germany.
    Kretlow A; Butzke D; Goetz ME; Grune B; Halder M; Henkler F; Liebsch M; Nobiling R; Oelgeschlaeger M; Reifenberg K; Schaefer B; Seiler A; Luch A
    ALTEX; 2010; 27(2):117-34. PubMed ID: 21445538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative test models for skin ageing research.
    Nakamura M; Haarmann-Stemmann T; Krutmann J; Morita A
    Exp Dermatol; 2018 May; 27(5):495-500. PubMed ID: 29478289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research on the Radiotoxicology of Plutonium Using Animals: Consideration of the 3Rs-Replace, Reduce, Refine.
    Griffiths NM; Van der Meeren A; Angulo JF; Vincent-Naulleau S
    Health Phys; 2020 Jul; 119(1):133-140. PubMed ID: 32301862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What if the number of nanotoxicity data is too small for developing predictive Nano-QSAR models? An alternative read-across based approach for filling data gaps.
    Gajewicz A
    Nanoscale; 2017 Jun; 9(24):8435-8448. PubMed ID: 28604902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Third International Conference on 3Rs Research and Progress, Vishakhapatnam, 2022.
    Naik NN; Vadloori B; Poosala S; Srivastava P; Coecke S; Smith A; Akhtar A; Roper C; Radhakrishnan S; Bhyravbhatla B; Damle M; Pulla VK; Hackethal J; Horland R; Li AP; Pati F; Singh MS; Occhetta P; Bisht R; Dandekar P; Bhagavatula K; Pajkrt D; Johnson M; Weber T; Huang J; Hysenaj L; Mallar B; Ramray B; Dixit S; Joshi S; Kulkarni M
    Altern Lab Anim; 2023 Jul; 51(4):263-288. PubMed ID: 37282515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alternative methods to animal testing, present and future].
    Marano F
    Biol Aujourdhui; 2023; 217(3-4):199-205. PubMed ID: 38018947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [AI-based QSAR Modeling for Prediction of Active Compounds in MIE/AOP].
    Uesawa Y
    Yakugaku Zasshi; 2020; 140(4):499-505. PubMed ID: 32238631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alternatives to animal testing].
    Fabre I
    Bull Acad Natl Med; 2009 Nov; 193(8):1783-91. PubMed ID: 20669543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Russell and Burch's 3Rs then and now: The case of Switzerland.
    Rodriguez Perez C; Persson K; Cajiga Morales RM; Elger BS; Shaw DM
    ALTEX; 2023; 40(4):635-648. PubMed ID: 37422923
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.